|
Mazziotta, J C; Frackowiak, R S; Phelps, M E (1992) The use of positron emission tomography in the clinical assessment of dementia. Semin Nucl Med 22:233-46
|
|
Engel Jr, J; Bandler, R; Griffith, N C et al. (1991) Neurobiological evidence for epilepsy-induced interictal disturbances. Adv Neurol 55:97-111
|
|
Luxen, A; Perlmutter, M; Bida, G T et al. (1990) Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET. Int J Rad Appl Instrum A 41:275-81
|
|
Melega, W P; Luxen, A; Perlmutter, M M et al. (1990) Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats. Biochem Pharmacol 39:1853-60
|
|
Melega, W P; Hoffman, J M; Luxen, A et al. (1990) The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans. Life Sci 47:149-57
|
|
Satyamurthy, N; Barrio, J R; Bida, G T et al. (1990) 3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans. Int J Rad Appl Instrum A 41:113-29
|
|
Barrio, J R; Satyamurthy, N; Huang, S C et al. (1989) 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. J Cereb Blood Flow Metab 9:830-9
|
|
Hawkins, R A; Huang, S C; Barrio, J R et al. (1989) Estimation of local cerebral protein synthesis rates with L-[1-11C]leucine and PET: methods, model, and results in animals and humans. J Cereb Blood Flow Metab 9:446-60
|
|
Melega, W P; Perlmutter, M M; Luxen, A et al. (1989) 4-[18F]fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography. J Neurochem 53:311-4
|
|
Keen, R E; Barrio, J R; Huang, S C et al. (1989) In vivo cerebral protein synthesis rates with leucyl-transfer RNA used as a precursor pool: determination of biochemical parameters to structure tracer kinetic models for positron emission tomography. J Cereb Blood Flow Metab 9:429-45
|
Showing the most recent 10 out of 27 publications
